Article info

Download PDFPDF

Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice

Authors

  1. Correspondence to Dr Jiu-Yao Wang; a122{at}mail.ncku.edu.tw
View Full Text

Citation

Hsieh P, Ho H, Hsieh S, et al
Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice

Publication history

  • Received November 12, 2019
  • Revised February 27, 2020
  • Accepted March 24, 2020
  • First published April 23, 2020.
Online issue publication 
April 23, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.